#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1100876	B	Inhibition of AFABP-mediated lipolysis in mouse 3T3L1 cells assessed as reduction in non-esterified fatty acid efflux after 24 hrs	Mus musculus	1		cell-based format	Scientific Literature
2.	ALA1100877	B	Inhibition of AFABP-mediated lipolysis in forskolin-stimulated mouse 3T3L1 cells assessed as reduction in non-esterified fatty acid efflux after 24 hrs	Mus musculus	1		cell-based format	Scientific Literature
3.	ALA3404797	B	Inhibition of FABP4 in mouse 3T3-L1 cells assessed as reduction of forskolin-induced lipolysis at 50 uM	Mus musculus	1		cell-based format	Scientific Literature
4.	ALA3404798	B	Inhibition of FABP4 in mouse 3T3-L1 cells assessed as reduction of forskolin-induced lipolysis at 100 uM	Mus musculus	1		cell-based format	Scientific Literature
5.	ALA3828891	B	Inhibition of FABP4 in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production after 24 hrs by ELISA	Mus musculus	3		cell-based format	Scientific Literature
6.	ALA3828892	B	Inhibition of FABP4 in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha expression after 24 hrs by qPCR method	Mus musculus	3		cell-based format	Scientific Literature
7.	ALA3828893	B	Inhibition of FABP4 in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 expression after 24 hrs by qPCR method	Mus musculus	3		cell-based format	Scientific Literature
8.	ALA4271672	B	Inhibition of FABP4 in mouse 3T3L1 cells assessed as reduction in forskolin-stimulated lipolysis by measuring reduction in glycerol level pretreated for 24 hrs followed by forskolin stimulation and measured after 2 hrs	Mus musculus	2		cell-based format	Scientific Literature
9.	ALA4271673	B	Inhibition of FABP4 in mouse 3T3L1 pre-adipocytes assessed as increase in triglyceride level at 50 uM treated for 6 days during differentiation period supplemented with fresh medium containing compounds for every 2 days measured post last dose	Mus musculus	2		cell-based format	Scientific Literature
10.	ALA4271674	B	Inhibition of FABP4 in mouse 3T3L1 pre-adipocytes assessed as increase in lipid accumulation at 50 uM treated for 6 days during differentiation period supplemented with fresh medium containing compounds for every 2 days measured post last dose by Oil red O staining based microscopic analysis	Mus musculus	2		cell-based format	Scientific Literature
11.	ALA4399649	B	Inhibition of FABP4 in mouse 3T3L1 cells assessed as inhibition of forskolin-stimulated lipolysis at 30 uM preincubated for 24 hrs followed by forskolin addition and measured after 2 hrs	Mus musculus	4		cell-based format	Scientific Literature
12.	ALA4399655	B	Inhibition of FABP4 in mouse RAW264.7 cells assessed as decrease in LPS-induced NF-kappaB phosphorylation at 30 to 60 uM preincubated for 12 hrs followed by LPS addition and measured after 10 mins by Western blot analysis	Mus musculus	4		cell-based format	Scientific Literature
13.	ALA4399656	B	Inhibition of FABP4 in mouse RAW264.7 cells assessed as decrease in LPS-induced IKK phosphorylation at 30 to 60 uM preincubated for 12 hrs followed by LPS addition and measured after 10 mins by Western blot analysis	Mus musculus	4		cell-based format	Scientific Literature
14.	ALA4605266	B	Inhibition of FABP4 in mouse 3T3L1 cells assessed as inhibition of forskolin-stimulated lipolysis by measuring free glycerol at 1 to 25 uM incubated for 24 hrs followed by forskolin stimulation and measured after 2 hrs	Mus musculus	2		cell-based format	Scientific Literature
15.	ALA4742607	B	Inhibition of fatty acid binding protein 4 in mouse 3T3-L1 cells assessed as reduction in adiponectin expression level at 10 uM dosed during day 2 to 6 and followed by drug replacement every 48 hrs by LC-MS/MS analysis based proteomic analysis	Mus musculus	1		organism-based format	Patent Bioactivity Data
16.	ALA4742608	B	Inhibition of fatty acid binding protein 4 in mouse 3T3-L1 cells assessed as reduction in sterol carrier protein 2 expression level at 10 uM dosed during day 2 to 6 and followed by drug replacement every 48 hrs by LC-MS/MS analysis based proteomic analysis	Mus musculus	1		organism-based format	Patent Bioactivity Data
17.	ALA4742609	B	Inhibition of fatty acid binding protein 4 in mouse 3T3-L1 cells assessed as reduction in cytochrome B5 Type A expression level at 10 uM dosed during day 2 to 6 and followed by drug replacement every 48 hrs by LC-MS/MS analysis based proteomic analysis	Mus musculus	1		organism-based format	Patent Bioactivity Data